Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype

PURPOSE: To determine the long-term prognosis in each phenotypic subset of breast cancer related to residual cancer burden (RCB) after neoadjuvant chemotherapy alone, or with concurrent human epidermal growth factor receptor 2 (HER2)–targeted treatment. METHODS: We conducted a pathologic review to m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Symmans, W. Fraser, Wei, Caimiao, Gould, Rebekah, Yu, Xian, Zhang, Ya, Liu, Mei, Walls, Andrew, Bousamra, Alex, Ramineni, Maheshwari, Sinn, Bruno, Hunt, Kelly, Buchholz, Thomas A., Valero, Vicente, Buzdar, Aman U., Yang, Wei, Brewster, Abenaa M., Moulder, Stacy, Pusztai, Lajos, Hatzis, Christos, Hortobagyi, Gabriel N.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2017
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5455352/
https://ncbi.nlm.nih.gov/pubmed/28135148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.63.1010
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados